The Estimation of Economic Burden of Hepatitis B Virus Infection in Iran
| Autor: | Mehdi Mohammadzadeh, Behnaz Fattahi, Tayebeh Ghari |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Hepatitis
Hepatitis B virus medicine.medical_specialty Hepatology business.industry Public health Social Welfare Hepatitis B medicine.disease medicine.disease_cause Virology 03 medical and health sciences Indirect costs 0302 clinical medicine Infectious Diseases Quality of life (healthcare) Environmental health medicine 030211 gastroenterology & hepatology 030212 general & internal medicine business Developed country |
| Zdroj: | Hepatitis Monthly. 17 |
| ISSN: | 1735-3408 1735-143X |
| DOI: | 10.5812/hepatmon.40541 |
| Popis: | One of the most important public health concerns in both developing and developed countries is viral hepatitis B. It is an autoimmune liver disease, which imposes a high economic burden on individuals and the society. The aim of our study was to determine economic burden of hepatitis B virus (HBV) infection in Iran. To this end, 300 patients with HBV infection, who referred to hospitals in three cities of Iran during the year 2015, were randomly selected. To estimate the total burden of hepatitis, direct and indirect costs, costs of DALYs and social welfare were calculated which gave the costs of 7500.93 PPP$ and 96782 PPP$, respectively. Finally, our results showed that the total economic burden of HBV in Iran is dramatic which can lead to decreased quality of life of household members and damage the economy of the society. Therefore, the benefit of prevention and control measures will justify the costs from social perspective. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|